FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Salem Enrique T
2. Issuer Name and Ticker or Trading Symbol

DOCUSIGN, INC. [ DOCU ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O BAIN CAPITAL VENTURE INVESTORS, LLC, 200 CLARENDON STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

7/2/2020
(Street)

BOSTON, MA 02116
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 7/2/2020  S  1000 D$180.257 (3)2035745 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  2920 D$182.014 (4)2032825 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  2100 D$182.6743 (5)2030725 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  3200 D$183.8808 (6)2027525 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  4805 D$185.1524 (7)2022720 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  6003 D$185.9395 (8)2016717 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  4810 D$187.1032 (9)2011907 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  5700 D$187.9972 (10)2006207 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  4784 D$189.1723 (11)2001423 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  4647 D$189.7831 (12)1996776 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  3735 D$191.0131 (13)1993041 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  2000 D$192.2865 (14)1991041 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  1500 D$193.4653 (15)1989541 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  1941 D$194.3347 (16)1987600 I See Footnotes (1)(2)
Common Stock 7/2/2020  S  100 D$194.98 1987500 I See Footnotes (1)(2)
Common Stock 7/6/2020  S  15000 D$197.6921 (17)152990 (18)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").
(2) Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.86 to $180.86, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (17) to this Form 4.
(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.40 to $182.38, inclusive.
(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.43 to $183.29, inclusive.
(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.44 to $184.35, inclusive.
(7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.50 to $185.49, inclusive.
(8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.51 to $186.49, inclusive.
(9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.53 to $187.52, inclusive.
(10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.57 to $188.50, inclusive.
(11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.59 to $189.59, inclusive.
(12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.60 to $190.46, inclusive.
(13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.62 to $191.48, inclusive.
(14) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.82 to $192.82, inclusive.
(15) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.88 to $193.83, inclusive.
(16) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.89 to $194.87, inclusive.
(17) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.50 to $197.815, inclusive.
(18) Includes 89,811 shares previously reported as indirectly owned by Mr. Salem through NPI Capital, LLC.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Salem Enrique T
C/O BAIN CAPITAL VENTURE INVESTORS, LLC
200 CLARENDON STREET
BOSTON, MA 02116
X



Signatures
/s/ Enrique T. Salem7/7/2020
**Signature of Reporting PersonDate

DocuSign (NASDAQ:DOCU)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more DocuSign Charts.
DocuSign (NASDAQ:DOCU)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more DocuSign Charts.